GEG Tech is proud to announce that a two-year collaborative research agreement has been sign with University Industry Foundation, Yonsei University Health System (YUHS). The purpose of this agreement is to establish a collaboration for research toward vectorization of the prime editing system for gene therapy.
YUHS will be responsible for evaluation of the potential of the vectors in gene therapy and GEG Tech will be responsible for different generations of DNA and RNA lentiviral vectors for prime editing system.
The term of the Agreement shall commence as of 02/07/2022 and terminates on 02/07/2024. The term may be extended by agreement of both Parties.
